BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31915844)

  • 21. The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias.
    Welihinda AA; Kaur M; Greene K; Zhai Y; Amento EP
    Cell Signal; 2016 Jun; 28(6):552-60. PubMed ID: 26903141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PET Imaging of the Adenosine A
    Schröder S; Lai TH; Toussaint M; Kranz M; Chovsepian A; Shang Q; Dukić-Stefanović S; Deuther-Conrad W; Teodoro R; Wenzel B; Moldovan RP; Pan-Montojo F; Brust P
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32252340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis.
    Anusha C; Sumathi T; Joseph LD
    Chem Biol Interact; 2017 May; 269():67-79. PubMed ID: 28389404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cajanus cajan (L) Millsp seeds extract prevents rotenone-induced motor- and non-motor features of Parkinson disease in mice: Insight into mechanisms of neuroprotection.
    Olubodun-Obadun TG; Ishola IO; Folarin OR; Oladoja FA; Gilbert TT; Aniekwensi IM; Bisiriyu A; Joseph-Iwebi NA; Adebanjo FO; Olopade JO; Adeyemi OO
    J Ethnopharmacol; 2024 Mar; 322():117623. PubMed ID: 38128890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-inflammatory, anti-apoptotic, and neuroprotective potentials of anethole in Parkinson's disease-like motor and non-motor symptoms induced by rotenone in rats.
    Moradi Vastegani S; Khoshnam SE; Mansouri E; Ghafouri S; Bakhtiari N; Farbood Y; Sarkaki A
    Metab Brain Dis; 2023 Aug; 38(6):2159-2174. PubMed ID: 37204660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson's Disease by GLP-1 Secretion.
    Sharma N; Soni R; Sharma M; Chatterjee S; Parihar N; Mukarram M; Kale R; Sayyed AA; Behera SK; Khairnar A
    Mol Neurobiol; 2022 Nov; 59(11):6834-6856. PubMed ID: 36048341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
    Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson's disease in rats.
    Habib CN; Mohamed MR; Tadros MG; Tolba MF; Menze ET; Masoud SI
    Eur J Pharmacol; 2022 Jan; 914():174573. PubMed ID: 34656609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oleanolic acid-based therapeutics ameliorate rotenone-induced motor and depressive behaviors in parkinsonian male mice via controlling neuroinflammation and activating Nrf2-BDNF-dopaminergic signaling pathways.
    Pingale TD; Gupta GL
    Toxicol Mech Methods; 2024 May; 34(4):335-349. PubMed ID: 38084769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotection of Rotenone-Induced Parkinsonism by Ursolic Acid in PD Mouse Model.
    Zahra W; Rai SN; Birla H; Singh SS; Rathore AS; Dilnashin H; Singh R; Keswani C; Singh RK; Singh SP
    CNS Neurol Disord Drug Targets; 2020; 19(7):527-540. PubMed ID: 32787765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
    Carriere CH; Kang NH; Niles LP
    Neuroscience; 2014 May; 267():114-21. PubMed ID: 24613722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
    Verma R; Nehru B
    Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
    Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H
    J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vinpocetine prevents rotenone-induced Parkinson disease motor and non-motor symptoms through attenuation of oxidative stress, neuroinflammation and α-synuclein expressions in rats.
    Ishola IO; Awogbindin IO; Olubodun-Obadun TG; Olajiga AE; Adeyemi OO
    Neurotoxicology; 2023 May; 96():37-52. PubMed ID: 36965781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sericin alleviates motor dysfunction by modulating inflammation and TrkB/BDNF signaling pathway in the rotenone-induced Parkinson's disease model.
    Salari Z; Ashabi G; Fartoosi A; Fartoosi A; Shariatpanahi M; Aghsami M; Montazeri H; Kheradmand A
    BMC Pharmacol Toxicol; 2023 Nov; 24(1):60. PubMed ID: 37936189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of inosine-mediated A
    Welihinda AA; Kaur M; Raveendran KS; Amento EP
    Cell Signal; 2018 Jan; 42():227-235. PubMed ID: 29126977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice.
    Inden M; Kitamura Y; Tamaki A; Yanagida T; Shibaike T; Yamamoto A; Takata K; Yasui H; Taira T; Ariga H; Taniguchi T
    Neurochem Int; 2009 Dec; 55(8):760-7. PubMed ID: 19647776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotection by caffeine in the MPTP model of parkinson's disease and its dependence on adenosine A2A receptors.
    Xu K; Di Luca DG; Orrú M; Xu Y; Chen JF; Schwarzschild MA
    Neuroscience; 2016 May; 322():129-37. PubMed ID: 26905951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective Effects of Filgrastim in Rotenone-Induced Parkinson's Disease in Rats: Insights into its Anti-Inflammatory, Neurotrophic, and Antiapoptotic Effects.
    Azmy MS; Menze ET; El-Naga RN; Tadros MG
    Mol Neurobiol; 2018 Aug; 55(8):6572-6588. PubMed ID: 29327204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cilostazol Mediated Nurr1 and Autophagy Enhancement: Neuroprotective Activity in Rat Rotenone PD Model.
    Hedya SA; Safar MM; Bahgat AK
    Mol Neurobiol; 2018 Sep; 55(9):7579-7587. PubMed ID: 29429051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.